$12.05 -0.98 (%) InVivo Therapeutics Holdings Corp - NASDAQ

Apr. 27, 2015 | 04:00 PM

Partner Headlines

  1. InVivo Therapeutics Receives FDA Conditional Approval for Proposed Protocol Changes

    Benzinga | Dec. 26, 2013 | 14:03PM EST
  2. (NVIV) CEO, CFO, 10% Owner Francis Reynolds sells 12,750 Shares

    GuruFocus | Feb. 13, 2013 | 14:06PM EST
  3. (NVIV) CEO, CFO, 10% Owner Francis Reynolds sells 12,750 Shares

    GuruFocus | Feb. 8, 2013 | 11:36AM EST
  4. (NVIV) CEO, CFO, 10% Owner Francis Reynolds sells 12,750 Shares

    GuruFocus | Feb. 5, 2013 | 15:36PM EST
  5. (NVIV) CEO, CFO, 10% Owner Francis Reynolds sells 9,600 Shares

    GuruFocus | Jan. 31, 2013 | 12:06PM EST
  6. (NVIV) CEO, CFO, 10% Owner Francis Reynolds sells 12,750 Shares

    GuruFocus | Jan. 23, 2013 | 11:36AM EST
  7. (NVIV) CEO, CFO, 10% Owner Francis Reynolds sells 12,750 Shares

    GuruFocus | Jan. 17, 2013 | 11:36AM EST
  8. (NVIV) CEO, CFO, 10% Owner Francis Reynolds sells 12,750 Shares

    GuruFocus | Jan. 14, 2013 | 11:35AM EST
  9. (NVIV) CEO, CFO, 10% Owner Francis Reynolds sells 12,750 Shares

    GuruFocus | Jan. 9, 2013 | 11:36AM EST
  10. InVivo Therapeutics Holdings Corp (NVIV) CEO, CFO, 10% Owner Francis Reynolds sells 12,750 Shares

    GuruFocus | Jan. 4, 2013 | 11:36AM EST
  11. InVivo Therapeutics Holdings Corp (NVIV) CEO, CFO, 10% Owner Francis Reynolds sells 12,750 Shares

    GuruFocus | Dec. 31, 2012 | 12:07PM EST
  12. InVivo Therapeutics Holdings Corp (NVIV) CEO, CFO, 10% Owner Francis Reynolds sells 12,750 Shares

    GuruFocus | Dec. 26, 2012 | 11:36AM EST
  13. InVivo Therapeutics Holdings Corp (NVIV) CEO, CFO, 10% Owner Francis Reynolds sells 8,500 Shares

    GuruFocus | Dec. 21, 2012 | 11:06AM EST
  14. InVivo Therapeutics Holdings Corp (NVIV) CEO, CFO, 10% Owner Francis Reynolds sells 12,750 Shares

    GuruFocus | Dec. 18, 2012 | 11:07AM EST
  15. InVivo Therapeutics Holdings Corp (NVIV) CEO, CFO, 10% Owner Francis Reynolds sells 12,750 Shares

    GuruFocus | Dec. 13, 2012 | 11:36AM EST
  16. InVivo Therapeutics Holdings Corp (NVIV) CEO, CFO, 10% Owner Francis Reynolds sells 12,750 Shares

    GuruFocus | Dec. 11, 2012 | 09:09AM EST
  17. InVivo Therapeutics Appoints Brian Hess as Interim Chief Science Officer

    Benzinga | Sep. 18, 2012 | 00:53AM EST
  18. Benzinga's Microcap Movers for Monday June 25, 2012

    Benzinga | Jun. 25, 2012 | 10:41AM EST
  19. InVivo Therapeutics Rises 22% on CEO Scheduled TV Appearances

    Benzinga | Jun. 25, 2012 | 06:53AM EST
  20. (NVIV) CEO, CFO, 10% Owner Francis Reynolds sells 250,000 Shares

    GuruFocus | Jan. 6, 2012 | 10:33AM EST
Trading Center